Industry
Medical - Devices
SI-BONE, Inc., a medical device company, develops implantable devices used to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers iFuse, a minimally invasive surgical implant system to address sacroiliac joint dysfunction and degeneration, adult deformity, and pelvic ring traumatic fractures. The company also provides iFuse-3D, a titanium implant that combines the triangular cross-section of the iFuse implant with the proprietary 3D-printed porous surface and fenestrated design; and iFuse-TORQ, a set of 3D-printed threaded implants designed to treat fractures of the pelvis and for minimally invasive sacroiliac joint fusion. It markets its products primarily with a direct sales force, as well as through distributors. The company was incorporated in 2008 and is headquartered in Santa Clara, California.
Loading...
Open
13.54
Mkt cap
563M
Volume
180K
High
13.54
P/E Ratio
-14.75
52-wk high
21.70
Low
13.10
Div yield
N/A
52-wk low
11.70
Portfolio Pulse from
November 26, 2024 | 4:00 pm
Portfolio Pulse from
November 13, 2024 | 4:00 am
Portfolio Pulse from
November 12, 2024 | 11:45 pm
Portfolio Pulse from
November 12, 2024 | 9:30 pm
Portfolio Pulse from Benzinga Insights
October 14, 2024 | 4:00 pm
Portfolio Pulse from Benzinga Newsdesk
October 14, 2024 | 2:25 pm
Portfolio Pulse from Benzinga Newsdesk
October 10, 2024 | 12:34 pm
Portfolio Pulse from Benzinga Newsdesk
August 20, 2024 | 12:38 pm
All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.